Skip to content

Epithelial Thickness Map

Comparison of Two Optical Coherence Tomography Devices in Corneal Epithelial Thickness Maps

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04578184
Enrollment
50
Registered
2020-10-08
Start date
2020-10-15
Completion date
2021-03-31
Last updated
2020-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Brief summary

In keratoconic eyes, the corneal epithelium shows a localized thinning over the cone that is surrounded by an annulus of epithelial thickening. It has been postulated that epithelial thickness mapping can be a sensitive tool for the keratoconus diagnosis. In keratoconus screening the 5 mm diameter of the corneal centrum may be sufficient while studies have shown that the cone apex is located in this area. Aim of this study is to assess agreement and repeatability of epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas. Secondary objective is to evaluate the differences between healthy and keratoconus eyes using epithelial thickness map data. This is a prospective monocentric study that includes patients divided into two groups: patients with keratoconus and a control group formed out of patients without corneal pathologies. For each patient only one eye will be included and corneal measurements will be performed, focused on the corneal epithelium thickness.

Detailed description

In total 50 eyes of 50 patients will be included, divided into two groups: study group comprised of 20 eyes with diagnosed keratoconus and a control group formed out of 30 healthy eyes. Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation. After each measurement patients will be asked to blink in order to allow adequate tear-film recovery. Each patient will be measured three times with both devices. Only one visit will be necessary. The order in which the measurements will be performed (Anterion or MS-39) will be randomised using randomised.org. The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces. Main outcome variable: \- Mean differences in central corneal epithelial thickness between the devices investigated (+ limits of agreement (1.96xSD) between the investigated devices) Secondary outcome variables: * Repeatability coefficient (within subject standard deviation - SD) and coefficient of variation of the two devices * Comparison in epithelial thickness between normal and keratoconus eyes * Sensitivity and specificity of swept-source OCT device in keratoconus diagnosis

Interventions

DIAGNOSTIC_TESTCorneal epithelial thickness measurements

Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.

Sponsors

Vienna Institute for Research in Ocular Surgery
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient with diagnosed keratoconus (diagnosed using tomography and topography map changes and slit-lamp changes) and patients with healthy cornea * Age 21 and older * Signed informed consent

Exclusion criteria

* Previous ocular surgery * Associated corneal pathologies (e.g. trauma, edema, scarring) * In women of childbearing age, a pregnancy test will be performed before inclusion into the study.

Design outcomes

Primary

MeasureTime frame
Agreement between two ss-OCT devices in corneal epithelial thickness measurements (LoA in micrometer)6 months

Secondary

MeasureTime frame
Repeatability between two ss-OCT devices in corneal epithelial thickness measurements (determination of within-subject standard deviation and Coefficient of variation)6 months

Countries

Austria

Contacts

Primary ContactOliver Findl, Prof., MD
hkh.augen.abt@wgkk.at+43 1 91021-84611
Backup ContactNino Hirnschall, MD, PhD
office@viros.at+43 1 91021 57564

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026